Avisi Technologies

CompanyUnited States

Avisi Technologies develops one asset, in human trials (VisiPlate Aqueous Shunt in open-angle glaucoma). Mostly device; based in the United States.

1
Asset
Furthest stage: Human trials; 2
Trials: 1
Signal

Pipeline

1

VisiPlate Aqueous Shunt
Aqueous shunt implant designed to lower intraocular pressure in glaucoma.
Human trials, Device, open-angle glaucoma

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials2
Signals2
Similar companies6